The Fifth Circuit Upholds Medicare Drug Price Negotiation: What NICA v. Kennedy Means for Houston Providers and Life Sciences

In NICA v. Kennedy the Fifth Circuit rejected constitutional challenges to the IRA drug pricing program. The fallout for Houston providers and life sciences firms.

BUSINESS LAW